Christophe Roberge
Directeur Technique/Scientifique/R&D chez MEDINCELL S.A.
Postes actifs de Christophe Roberge
Sociétés | Poste | Début | Fin |
---|---|---|---|
MEDINCELL S.A. | Directeur Technique/Scientifique/R&D | 01/05/2016 | - |
Historique de carrière de Christophe Roberge
Anciens postes connus de Christophe Roberge
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Corporate Officer/Principal | 01/01/2003 | 01/01/2008 |
Formation de Christophe Roberge
Institut National de la Recherche Scientifique | Doctorate Degree |
Statistiques
Internationale
Canada | 2 |
France | 2 |
2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
MEDINCELL S.A. | Health Technology |
Entreprise privées | 1 |
---|---|
BioArtificial Gel Technologies, Inc.
BioArtificial Gel Technologies, Inc. Pharmaceuticals: MajorHealth Technology BioArtificial Gel Technologies, Inc. develops and manufactures pharmaceutical products. It products are used for wound care therapeutics and skin care. The company was founded by Marie-Pierre Faure in 1998 and is headquartered in Montréal, Canada. | Health Technology |
- Bourse
- Insiders
- Christophe Roberge
- Expérience